DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 188 filers reported holding DIPLOMAT PHARMACY INC in Q3 2016. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $37,472,000 | -17.8% | 9,368,042 | +0.7% | 0.00% | -50.0% |
| Q3 2019 | $45,588,000 | -18.2% | 9,303,358 | +1.6% | 0.00% | 0.0% |
| Q2 2019 | $55,749,000 | +12.4% | 9,154,249 | +7.2% | 0.00% | 0.0% |
| Q1 2019 | $49,613,000 | -57.4% | 8,539,331 | -1.3% | 0.00% | -66.7% |
| Q4 2018 | $116,435,000 | -29.1% | 8,650,451 | +2.2% | 0.01% | -14.3% |
| Q3 2018 | $164,292,000 | -11.2% | 8,464,251 | +17.0% | 0.01% | -22.2% |
| Q2 2018 | $184,946,000 | +41.0% | 7,235,761 | +11.1% | 0.01% | +50.0% |
| Q1 2018 | $131,193,000 | -3.2% | 6,510,836 | -3.6% | 0.01% | 0.0% |
| Q4 2017 | $135,566,000 | +0.4% | 6,754,710 | +3.6% | 0.01% | -14.3% |
| Q3 2017 | $134,971,000 | +60.7% | 6,517,210 | +14.9% | 0.01% | +75.0% |
| Q2 2017 | $83,983,000 | -5.1% | 5,674,514 | +2.3% | 0.00% | -20.0% |
| Q1 2017 | $88,501,000 | +201038.6% | 5,548,617 | +158977.3% | 0.01% | – |
| Q4 2016 | $44,000 | -59.6% | 3,488 | -10.9% | 0.00% | – |
| Q3 2016 | $109,000 | -55.0% | 3,916 | -43.3% | 0.00% | – |
| Q2 2016 | $242,000 | +255.9% | 6,912 | +175.7% | 0.00% | – |
| Q1 2016 | $68,000 | +74.4% | 2,507 | +118.0% | 0.00% | – |
| Q4 2015 | $39,000 | +56.0% | 1,150 | +36.1% | 0.00% | – |
| Q3 2015 | $25,000 | -45.7% | 845 | -17.7% | 0.00% | – |
| Q2 2015 | $46,000 | +21.1% | 1,027 | -6.9% | 0.00% | – |
| Q1 2015 | $38,000 | -2.6% | 1,103 | -23.1% | 0.00% | – |
| Q4 2014 | $39,000 | – | 1,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|